Seller record · Telehealth service

Found

Fails 2 of 8 criteria. S3, pharmacy identification: Found partners exclusively with 503A-licensed pharmacies, and no filling facility is named anywhere on the site. 1 more criterion also fails; see the table below.

At a glance

FoundTelehealth service

6/8criteria passed
Price
$289 a month, or $169 a month paid yearly
Sells
compounded semaglutide, compounded tirzepatide, brand GLP-1 drugs, and 4 more
FDA letters
None on file

Partner link. The site earns a commission on care started through it. Funding

Visit FoundSee all eight dispositions

Telehealth service. Passes 6 of 8 criteria. Recorded against Standard v1.1.

A telehealth weight care service selling compounded and brand GLP-1 drugs, and billing insurance. It names its medical groups but not its pharmacies.

Operating entity Found Health, Inc.

Dispositions

CodeCriterionDispositionWhere it appears
S1Prescriber requirementPASSFound's terms and conditions
S2Prescription gatingPASSFound's health assessment survey page on its clinic storefront
S3Pharmacy identificationFAILFound's compounded semaglutide product page
S4Compounding disclosurePASSFound's compounded semaglutide product page
S5Analytical documentationFAILFound's compounded semaglutide product page
S6Business addressPASSFound's terms and conditions
S7Price disclosurePASSFound's plans and pricing page
S8Enforcement statusPASSFDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSA board-certified clinician reviews each assessment; the terms name Pippen Health and Cloud Health Medical Group as the medical groups.Source: Found's terms and conditions.
S2PASSThe eligibility quiz welcome screen stops the order, before any price or payment appears.Source: Found's health assessment survey page on its clinic storefront.
S3FAILFound partners exclusively with 503A-licensed pharmacies, and no filling facility is named anywhere on the site.Source: Found's compounded semaglutide product page.
S4PASSCompounded GLP-1 drugs are not FDA-approved or evaluated for safety or efficacy, printed on the compounded semaglutide page.Source: Found's compounded semaglutide product page.
S5FAILA comparison table states that medication is independently tested for potency, purity and sterility, and no report is reachable.Source: Found's compounded semaglutide product page.
S6PASSFound Health, Inc. at 215 NW 24th St, Suite 700, Miami, Florida 33127, printed in the terms of service.Source: Found's terms and conditions.
S7PASSCash pay is printed at 169 dollars per month on a twelve-month plan paid up front, and at 289 dollars on a monthly plan.Source: Found's plans and pricing page.
S8PASSNo FDA warning letter names the entity, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide, brand GLP-1 drugs, metformin, topiramate, zonisamide, orforglipron.

Other sellers of the same products

Who sells semaglutideWho sells tirzepatide

Partner link. The site earns a commission on care started through it. Funding.

Visit Found

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.